Title Autophagy loss impedes cancer-associated fibroblast activation via downregulating proline biosynthesis
Authors Bai, Jingru
Liu, Tong
Tu, Bo
Yuan, Meng
Shu, Zhaoqi
Fan, Minghe
Huo, Sihan
Guo, Yuyao
Wang, Lina
Wang, Hua
Zhao, Ying
Affiliation Peking Univ, Hlth Sci Ctr, Beijing Key Lab Prot Posttranslat Modificat & Cel, Dept Biochem & Mol Biol,Sch Basic Med Sci, Beijing, Peoples R China
Shenzhen Univ, Sch Med, Marshall Lab Biomed Engn, Hong Kong, Peoples R China
Peking Univ Third Hosp, Inst Med Innovat & Res, Beijing, Peoples R China
Fred Hutchinson Canc Res Ctr, Clin Res Div, 1124 Columbia St, Seattle, WA 98104 USA
Peking Univ, Peking Univ Third Hosp, Hlth Sci Ctr, Dept Pathol,Sch Basic Med Sci, Beijing, Peoples R China
Keywords PANCREATIC STELLATE CELLS
TUMORS
MITOCHONDRIA
GENERATION
GROWTH
KRAS
Issue Date Jul-2022
Publisher AUTOPHAGY
Abstract Cancer-associated fibroblasts (CAFs) are considered one of the most critical stromal cells that interact with pancreatic ductal adenocarcinoma (PDAC) and promote tumor growth, metastasis, and treatment resistance. Previous studies illustrated macroautophagy/autophagy contributes to CAF activation during tumor progression. Here in our study, we found that autophagy deficiency in CAFs impedes CAF activation by inhibiting proline biosynthesis and collagen production. Furthermore, we uncovered that autophagy promotes proline biosynthesis through mitophagy-mediated regulation of NADK2 (NAD kinase 2, mitochondrial), an enzyme responsible for production of mitochondrial NADP(H). Using an orthotopic mouse model of PDAC, we found that inhibiting mitophagy by targeting PRKN (parkin RBR E3 ubiquitin protein ligase) in the stroma reduced tumor weight. Thus, inhibition of CAFs mitophagy might be an attractive strategy for stroma-focused anti-cancer intervention.
URI http://hdl.handle.net/20.500.11897/649072
ISSN 1554-8627
DOI 10.1080/15548627.2022.2093026
Indexed SCI(E)
Appears in Collections: 第三医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.